Emcure Pharmaceuticals dividend 2025

EMCURE

1381.4

14.00 (-1.00%)
Last updated on 16 Dec, 2025 | 15:58 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Emcure Pharmaceuticals Dividend Details

Record Date

14-Aug-2025

Dividends Date

14-Aug-2025

Ex Date

14-Aug-2025

Dividend Type

Equity Share

Dividend Per Share

30.00

The Emcure Pharmaceuticals has declared a Equity Share dividend of 30 per share. Investors should note the record date of 14-Aug-2025, and the ex-dividend date 14-Aug-2025 to confirm eligibility for the payout. This move underscores the company’s ongoing efforts to enhance shareholder value through regular dividend distributions.

Emcure Pharmaceuticals Dividend History

Record DateDividend Per ShareDividend TypeEx-Date
14-Aug-20250.30Equity Share14-Aug-2025

Upcoming Dividends by Indian Companies

View More
CompanyDividends RatioAnnouncementRecord DateDividends Date
Can Fin Homes Ltd.008-Dec-202519-Dec-202519-Dec-2025

Emcure Pharmaceuticals Dividend FAQs

The latest dividend declared by Emcure Pharmaceuticals is of 0.3 per share for the financial year as announced on 14-Aug-2025.

Registered shareholders who own Emcure Pharmaceuticals’s shares on or before the record date of 14-Aug-2025 set by the company are eligible to receive the dividend. You will not be entitled to the payout if you purchase shares on or after the ex-dividend date of 14-Aug-2025.

You can expect to receive Emcure Pharmaceuticals’s dividend in your bank account linked to your Demat account within 25 to 45 business days after the record date of 14-Aug-2025. The record date is when Emcure Pharmaceuticals identifies eligible shareholders for the dividend payment.

The annual dividend paid by Emcure Pharmaceuticals varies according to its financial performance and dividend policy. Generally, companies in different sectors exhibit varying dividend yields. To determine Emcure Pharmaceuticals's specific annual dividend, it’s advisable to consult the company's official investor relations website or recent financial statements.